+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Technology Innovations and Growth Opportunities for COVID-19, Digital Pathology, Cancer, Stress, Pain, and Obesity

  • ID: 5128943
  • Report
  • April 2020
  • Region: Global
  • 64 Pages
  • Frost & Sullivan

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses recent innovations in life sciences, health & wellness. The research encompasses recent advances across digital pathology, COVID-19 management, cancer treatment, pain therapy, and an obesity drug among several other innovations. The TOE also provides valuable growth opportunities within each innovation landscape.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.


Note: Product cover images may vary from those shown

1. Recent Advances Fuelling Life Sciences, Health & Wellness


  • Dyskinesia Drug Enters Phase II Clinical Trial
  • Enabling a Groundbreaking Cure for Dyskinesia
  • Deep Learning AI Driving Broad Digital Pathology Fields
  • Opportunities Across Industries/ Applications
  • Next Generation Scanning for Whole Slide Imaging
  • Transforming Digital Pathology across Europe
  • Cloud-based, Seamlessly Integrated Telepathology
  • Improving Clinical Diagnostics
  • Open, Multi-vendor, End-to-end Digital Pathology Solution
  • Transforming Digital Pathology with Cancer Therapy
  • Developing COVID-19 Vaccine Using Tobacco Leaves
  • Preventing COVID-19
  • Repurposing of Cancer Drug Acalabrutinib for the Treatment of COVID-19
  • Acalabrutinib Likely to Improve COVID-19 Management
  • Technology Attributes
  • Opportunities Across Industries/ Applications
  • Non-opioid Analgesic for Post-operative Pain Relief
  • Drug to Prevent Kidney Damage from Systemic Lupus Erythematosus
  • Opportunities Across Industries/ Applications
  • Blood Filters to Stabilize Hemodynamics
  • Blood Filters for COVID19
  • Nanoparticles to Reduce Stress
  • CAR-M Therapy for the Treatment of Ovarian Cancer
  • Re-growing Muscles Using New Innovations
  • Niacin to Treat Glioblastoma
  • Advances in Treating Multiple Myeloma Using CART- Cell Therapy
  • Targeting CD229 for Multiple Myeloma Treatment
  • New Drug to Treat Obesity
  • Small Molecule Targeting Gut Microbiome
  • Peptide Therapeutics for COVID-19 Treatment
  • The mRNA-based Vaccine for COVID-19
  • Unique Nucleic Acid-based Vaccines and Therapeutics
  • Groundbreaking DNA Immunotherapy Platform
  • Recombinant Enzyme: A Potential Therapy for COVID-19
  • High-Performance Aerosol Drug Delivery
  • Three Gene-specific Detection of SARS-CoV-2
  • Novel Antiviral and RNAi Medicines
  • Activating Innate Immune Response to Fight COVID-19

2. Industry Influencers


  • Key Contacts
Note: Product cover images may vary from those shown